It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Whipworms are large metazoan parasites that inhabit multi-intracellular epithelial tunnels in the large intestine of their hosts, causing chronic disease in humans and other mammals. How first-stage larvae invade host epithelia and establish infection remains unclear. Here we investigate early infection events using both Trichuris muris infections of mice and murine caecaloids, the first in-vitro system for whipworm infection and organoid model for live helminths. We show that larvae degrade mucus layers to access epithelial cells. In early syncytial tunnels, larvae are completely intracellular, woven through multiple live dividing cells. Using single-cell RNA sequencing of infected mouse caecum, we reveal that progression of infection results in cell damage and an expansion of enterocytes expressing of Isg15, potentially instigating the host immune response to the whipworm and tissue repair. Our results unravel intestinal epithelium invasion by whipworms and reveal specific host-parasite interactions that allow the whipworm to establish its multi-intracellular niche.
Whipworms are large parasites causing chronic disease in humans and other mammals. Here, the authors show how larvae create tunnels inside the gut lining and reveal the early host response to infection via Isg15 in mice and murine caecaloids.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); University of Cambridge, Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
2 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672)
3 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); Mogrify Ltd, 25 Cambridge Science Park, Cambridge, UK (GRID:grid.52788.30)
4 University of Cambridge, Department of Zoology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
5 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
6 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); Genentech, 1 DNA Way, South San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718)
7 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); University of Cambridge, Wellcome/Cancer Research UK Gurdon Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
8 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); InstilBio, UMIC Bio-Incubator, Manchester, UK (GRID:grid.5379.8)
9 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Prime Global Medical Communications, Knutsford, UK (GRID:grid.5379.8)
10 University of Barcelona, Faculty of Biology, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
11 Federal University of Ouro Preto, Campus Universitario Morro do Cruzeiro, Immunopathology Laboratory, NUPEB, Ouro Preto, Brazil (GRID:grid.411213.4) (ISNI:0000 0004 0488 4317)
12 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Rosalind Franklin Institute, Didcot, UK (GRID:grid.507854.b)